Peter Rahmer sold $300K of Relay Therapeutics (RLAY)

Executed Oct 28 2025, disclosed Oct 30 2025, 2 days later.

Value, as filed

$300K

40,529 sh across 2 lots

Executed

Oct 28 2025

the trade date, as filed

Disclosed

Oct 30 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Peter Rahmer See remarks profile →

Peter Rahmer (See remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $954K of RLAY (50,000 sh × $19.09, as filed), executed Jun 30.

The name

RLAY

Relay Therapeutics, Inc. RLAY · Healthcare · 32 filings in 24 months ticker →

Healthcare · Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Peter Rahmer in RLAY

RLAYSALE Relay Therapeutics, Inc. $954K
50,000 sh × $19.09
Exec Jun 30
Filed Jul 2 · 4:12 PM ET RLAYSALE Relay Therapeutics, Inc. $121K
26,541 sh × $4.55
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $272K
64,333 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET